Differential expression of CDX2 and GCDFP-15 may help distinguishing primary vs. secondary PPD, which is important for management as the presence of an underlying malignancy impacts clinical course and prognosis. Here, CDX2 is linked to progressive pseudorheumatoid arthropathy of childhood.